MERCK & CO. INC.
MRKNYSE🏆 #36 by market capEarnings Oct 29 · PreUS Equity
$141.09▼ $0.75 (−0.53%)
After hours · at closeTrack MRK
Get earnings, price moves & breaking news on Telegram
24h▼ 0.5%
7d▼ 5.9%
14d▼ 4.3%
30d▼ 5.1%
ytd▲ 34.0%
1y▲ 62.1%
🏦Market Cap
$348.09B
Large Cap
📈Revenue Growth (YoY)
4.6%
Slowing
📊Gross Margin
77.3%
High
💵FCF Margin
24.1%
Strong
⚖️P/S Ratio
5.4x
Fair
Otter Score
72
Strong
MERCK & CO. INC.
MRKAnalyst Ratings
Price
$141.09
Total
19
Raised
16
Lowered
2
Avg PT
$162.47
H / L
$180 / $138
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Barclays Merck & Co | Raised | Overweight | 2026-10-26 | $180.00 | +27.60% |
Scotiabank Merck & Co | Raised | Sector Outperform | 2026-09-29 | $180.00 | +27.60% |
Wolfe Research Merck & Co | Raised | Outperform | 2026-08-25 | $180.00 | +27.60% |
Morgan Stanley Merck & Co | Lowered | Overweight | 2026-10-07 | $177.00 | +25.50% |
UBS Merck & Co | Raised | Buy | 2026-08-20 | $175.00 | +24.00% |
HSBC Merck & Co | Raised | Buy | 2026-09-10 | $172.00 | +21.90% |
Guggenheim Merck & Co | Raised | Buy | 2026-09-08 | $170.00 | +20.50% |
Wells Fargo Merck & Co | Raised | Overweight | 2026-09-04 | $170.00 | +20.50% |
Argus Research Merck & Co | Raised | Buy | 2026-08-25 | $170.00 | +20.50% |
BMO Capital Merck & Co | Raised | Outperform | 2026-08-20 | $170.00 | +20.50% |
JP Morgan Merck & Co | Raised | Overweight | 2026-10-05 | $165.00 | +16.90% |
Leerink Partners Merck & Co | Raised | Outperform | 2026-09-09 | $161.00 | +14.10% |
Goldman Sachs Merck & Co | Raised | Buy | 2026-08-21 | $160.00 | +13.40% |
Citigroup Merck & Co | Raised | Neutral | 2026-10-12 | $145.00 | +2.80% |
RBC Capital Merck & Co | Lowered | Sector Perform | 2026-10-12 | $145.00 | +2.80% |
Cantor Fitzgerald Merck & Co | Raised | Neutral | 2026-10-08 | $145.00 | +2.80% |
Daiwa Capital Merck & Co | Raised | Neutral → Outperform | 2026-08-12 | $143.00 | +1.40% |
B of A Securities Merck & Co | Raised | Buy | 2026-06-30 | $141.00 | −0.10% |
CICC Merck & Co | Initiated | Outperform | 2026-06-24 | $138.00 | −2.20% |
Institution
Barclays
Raised · Overweight · 2026-10-26
$180.00
+27.60%
Scotiabank
Raised · Sector Outperform · 2026-09-29
$180.00
+27.60%
Wolfe Research
Raised · Outperform · 2026-08-25
$180.00
+27.60%
Morgan Stanley
Lowered · Overweight · 2026-10-07
$177.00
+25.50%
UBS
Raised · Buy · 2026-08-20
$175.00
+24.00%
HSBC
Raised · Buy · 2026-09-10
$172.00
+21.90%
Guggenheim
Raised · Buy · 2026-09-08
$170.00
+20.50%
Wells Fargo
Raised · Overweight · 2026-09-04
$170.00
+20.50%
Argus Research
Raised · Buy · 2026-08-25
$170.00
+20.50%
BMO Capital
Raised · Outperform · 2026-08-20
$170.00
+20.50%
JP Morgan
Raised · Overweight · 2026-10-05
$165.00
+16.90%
Leerink Partners
Raised · Outperform · 2026-09-09
$161.00
+14.10%
Goldman Sachs
Raised · Buy · 2026-08-21
$160.00
+13.40%
Citigroup
Raised · Neutral · 2026-10-12
$145.00
+2.80%
RBC Capital
Lowered · Sector Perform · 2026-10-12
$145.00
+2.80%
Cantor Fitzgerald
Raised · Neutral · 2026-10-08
$145.00
+2.80%
Daiwa Capital
Raised · Neutral → Outperform · 2026-08-12
$143.00
+1.40%
B of A Securities
Raised · Buy · 2026-06-30
$141.00
−0.10%
CICC
Initiated · Outperform · 2026-06-24
$138.00
−2.20%
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space